BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Radiopharmaceuticals

  Radiopharma Powerhouses Push Frontiers With New Indications, Innovation

  At the intersection of radiation and precision, Novartis, Bayer, AstraZeneca and more hope to cash in on a radiopharmaceuticals market that could top $16 billion by 2033.

  May 12, 2025

   · 

  9 min read

   · 

  Tristan Manalac
• Press Releases

  Alnylam to Share Progress Across its Transthyretin Amyloidosis Franchise Including Additional Analyses of the HELIOS-B Phase 3 Study Results at Heart Failure 2025 Congress

  May 12, 2025

   · 

  5 min read
• Press Releases

  Clearmind Medicine Announces Publication of European Patent for Psychedelic-Based Combination Therapy for Cocaine Addiction

  May 12, 2025

   · 

  5 min read
• Press Releases

  Alterity Therapeutics Prominently Featured at the International MSA Congress

  May 12, 2025

   · 

  13 min read
• Press Releases

  BridgeBio to Present Clinical Outcomes, Quality of Life Measures and Incidence of Atrial Fibrillation Events in Patients with ATTR-CM from the ATTRibute-CM Study at the Annual Congress of the Heart Failure Association of the ESC

  May 12, 2025

   · 

  3 min read
• Press Releases

  Hoth Therapeutics Reports Positive Preclinical Results for HT-KIT, a Precision Antisense Therapy Targeting Rare and Aggressive KIT-Driven Cancers

  May 12, 2025

   · 

  6 min read
• Press Releases

  Agenus Reports Q1 2025 Financial Results and Key Business Updates

  May 12, 2025

   · 

  7 min read
• Press Releases

  ABLi Therapeutics Launches with a Focus on Developing Treatments for Neurodegenerative Diseases that Arise from Activation of c-Abl Kinases

  May 12, 2025

   · 

  4 min read
• Press Releases

  NeurAxis Reports Strong First Quarter 2025 Financial Results Driven by a 39% Growth in Revenues

  May 12, 2025

   · 

  9 min read
• Press Releases

  Opus Genetics Announces Presentations on Inherited Retinal Disease Programs at Medical Conferences in May

  May 12, 2025

   · 

  10 min read